Article
Mutations of the serine protease CAP1/Prss8 lead to reduced embryonic viability, skin defects, and decreased ENaC activity.
The American journal of pathology - 1 Aug 2012
Frateschi Simona, Keppner Anna, Malsure Sumedha, Iwaszkiewicz Justyna, Sergi Chloé, Merillat Anne-Marie, Fowler-Jaeger Nicole, Randrianarison Nadia, Planès Carole, Hummler Edith
Abstract excerpt
CAP1/Prss8 is a membrane-bound serine protease involved in the regulation of several different effectors, such as the epithelial sodium channel ENaC, the protease-activated receptor PAR2, the tight junction proteins, and the profilaggrin polypeptide. Recently, the V170D and the G54-P57 deletion mutations within the CAP1/Prss8 gene, identified in mouse frizzy (fr) and rat hairless (fr(CR)) animals, respectively,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
